• Putative kidney progenitor cells contribute to kidney function decline by causing kidney scarring. Targeting these cells may therefore help prevent or treat kidney failure.
• Researchers have identified an additional but limited reserve of kidney filtering cells that are present at birth and become mature and functional filter cells by adulthood.
60 million people globally have chronic kidney disease; 2 million have kidney failure.
Newswise — Washington, DC (January 9, 2014) — New research reveals that certain cells contribute to kidney function decline, making them attractive targets for treatments against kidney failure. The findings will appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
The blood-filtering cells in the kidneys—called podocytes—are critical to kidney function, and kidney failure can occur when as little as about 20% to 30% of them are lost. Marcus Moeller, MD, Bart Smeets, PhD, Katja Berger (RWTH University of Aachen, in Germany), and their colleagues looked to see if they could coax podocytes to be generated from putative kidney progenitor cells—termed parietal cells—as a potential treatment strategy for kidney failure.
Through experiments conducted in mice, the researchers found that podocytes cannot be renewed from parietal cells. In fact, after the loss of podocytes, parietal cells play a negative role by causing kidney scarring that contributes to progressive kidney function decline. “This opens a very important new strategy to prevent loss of kidney function: by inhibiting the parietal cells from doing their destructive work,” said Dr. Moeller.
The researchers did, however, detect an additional but limited reserve of podocytes that are present at birth and become mature and functional filter cells by adulthood.
“Our results indicate that research efforts should be directed towards preserving our limited pool of filter cells and to develop pharmacological strategies to inhibit scarring of the kidney by parietal cells,” said Dr. Moeller.
Study co-authors include Kevin Schulte, MD, Peter Boor, MD, Christoph Kuppe, MD, Toin van Kuppevelt, MD, and Jürgen Floege, MD.
Disclosures: The authors reported no financial disclosures.
The article, entitled “The Regenerative Potential of Parietal Epithelial Cells in Adult Mice,” will appear online at http://jasn.asnjournals.org/ on January 9, 2014.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.